• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Arch Therapeutics, Inc. – Ticker: ARTH

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding
(hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products
based on an innovative self-assembling peptide technology platform to make surgery and interventional
care faster and safer for patients. Arch’s flagship development stage product candidate, known as the
AC5 Surgical Hemostatic Device, is being designed to achieve hemostasis in minimally invasive and open
surgical procedures.

Web Site: ArchTherapeutics.com

About

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

POST YOUR COMMENTS

Public Wire Banner